Drug intelligence / Profile preview

MDC-007

Development stage
Preclinical
Lead developer
MediciBio
Modality
mRNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
01

Overview

MDC-007 is an actively targeted lipid nanoparticle (LNP) delivery system developed by MediciBio. It utilizes antibody or aptamer ligand conjugation to achieve cell-specific delivery of mRNA or siRNA payloads. The platform is designed to target a variety of cell types, including cancer cells and immune cells such as T cells, monocytes, macrophages, and natural killer (NK) cells. Its primary applications include cancer therapies, immunotherapies, and the generation of in vivo CAR therapies, where genetic instructions are delivered directly to immune cells to enable targeted anti-tumor activity.

Beyond the preview

Go deeper on MDC-007.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MDC-007.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call